Impacts of surgical interventions on the long-term outcomes in individuals with trisomy 18

Chiaki Iida1, Jun Muneuchi1, Junko Yamamoto1

  • 1Department of Pediatrics, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1, Kishinoura, Yahatanishiku, Kitakyushu, 806-8501, Japan.

Insights

Surgical interventions in trisomy 18 (T18) patients do not improve long-term survival but can enhance the ability to achieve homecare. This study analyzed 69 T18 individuals, comparing surgical versus conservative treatment outcomes.

Area of Science:

  • Medical research
  • Pediatric surgery
  • Genetics and rare diseases

Background:

  • Trisomy 18 (T18) is a severe genetic disorder associated with significant morbidity and mortality.
  • The role of surgical interventions in improving long-term outcomes for individuals with T18 remains unclear.
  • Congenital anomalies, particularly heart defects, are common in T18 patients, often necessitating medical and surgical consideration.

Purpose of the Study:

  • To investigate the impact of surgical interventions on long-term survival and homecare achievement in individuals with trisomy 18.
  • To compare outcomes between T18 patients who received surgical treatment versus those who received conservative management.

Main Methods:

  • Retrospective analysis of 69 individuals with trisomy 18 admitted to four tertiary neonatal centers (2003-2017).
  • Patients were categorized into two groups: those undergoing surgical interventions (cardiac, digestive) and those receiving conservative treatment.
  • Comparison of survival rates and rates of achieving homecare between the two groups, with Cox hazard analysis for prognostic factors.

Main Results:

  • No significant difference in survival rates was observed between the surgical and conservative treatment groups (p=0.26).
  • Surgical interventions were associated with a significantly higher rate of achieving homecare (p=0.02).
  • Prenatal diagnosis, cardiac surgery, and digestive surgery were identified as factors related to achieving homecare.

Conclusions:

  • Aggressive surgical interventions in trisomy 18 patients do not enhance long-term survival.
  • Surgical interventions may positively influence the ability of individuals with trisomy 18 to achieve homecare.
  • Further research is warranted to delineate the specific benefits and risks of surgical approaches in this population.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
821
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
216.9K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
69.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K